Option Care Health Profit Margin 2010-2023 | OPCH

Current and historical gross margin, operating margin and net profit margin for Option Care Health (OPCH) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Option Care Health net profit margin as of December 31, 2023 is 6.15%.
Option Care Health Annual Profit Margins
Option Care Health Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $5.147B $4.302B
Option Care Health Inc provides infusion and home care management solutions. The Company offers products, services and condition-specific clinical management programs for gastrointestinal abnormalities, infectious diseases, cancer, organ and blood cell transplants, bleeding disorders and heart failures. Option Care Health Inc., formerly known as BioScrip Inc., is based in Denver, United States.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.392B 9.92
Quest Diagnostics (DGX) United States $14.915B 15.41
DaVita (DVA) United States $11.709B 15.93
Chemed (CHE) United States $8.472B 26.30
Encompass Health (EHC) United States $8.259B 21.25
Elanco Animal Health (ELAN) United States $6.552B 14.90
RadNet (RDNT) United States $3.314B 96.80
Amedisys (AMED) United States $2.999B 21.25
LifeStance Health (LFST) United States $2.370B 0.00
Astrana Health (ASTH) United States $2.057B 25.68
Addus HomeCare (ADUS) United States $1.548B 23.52
U.S Physical Therapy (USPH) United States $1.516B 39.30
Pennant (PNTG) United States $0.624B 36.46
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.323B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00